Physician Payment & Practice

PULSE 11/20/2026: NYRx MSSNY Meeting Recap

NYRx MSSNY Meeting Recap Click to Enlarge Practitioner Administered Drug went live for Fee-for-Service members on November 19. The Preferred Drug List has been renamed NYRx Clinical Criteria and Cover Guide and is in ADA-compliant formatting. Vyvanse and Carbatrol have been

PULSE 11/20/2026: Dispute Processing is Available in the IDR Gateway

Dispute Processing is Available in the IDR Gateway Click to Enlarge Beginning November 13, 2026, organizations with IDR Gateway accounts can submit “Notice of IDR Initiation,” “Notice of IDR Initiation Response,” “Notice of Certified IDR Entity Selection,” and “Notice of

PULSE 11/13/2026: Action Alert: Incorrect Insurer Processing of Office-Administered Drugs (UnitedHealthcare)

Action Alert: Incorrect Insurer Processing of Office-Administered Drugs (UnitedHealthcare) Click to Enlarge MSSNY is currently tracking a systematic claims processing issue involving UnitedHealthcare and physician-administered drugs billed on CMS-1500 claims forms. What Happened The Issue: Claims for physician-administered drugs given

PULSE 10/23/2026: Provider-Administered Drugs Webinar Update

Provider-Administered Drugs Webinar Update Click to Enlarge NYRx, the Medicaid Drug Program, will host an additional webinar on PADs (Provider-Administered Drugs) on Monday, November 9 at 10:00 AM. Physicians are welcome to attend. The presentation will share updates and provide

PULSE 10/16/2026: NYRx: PDL & Prior Auth Updates

NYRx Cost Optimization Program Update Click to Enlarge NYRx’s September 10 Cost Optimization update and current Preferred Drug List (PDL) are available. Additional PDL and Brand Less Than Generic (BLTG) changes are scheduled for October 22. Beginning in November, prior

PULSE 7/31/2026: Payment & Practice: Turning Complex Payer Challenges Into $45 Million Recovered Revenue

Payment & Practice: Turning Complex Payer Challenges Into $45 Million Recovered Revenue Click to Enlarge Payer disputes can drain time, revenue, and staff capacity from practices already managing rising costs, workforce pressures, and growing administrative demands. For New York physicians,

PULSE 7/24/2026: NYRx Cost Optimization Program Update

NYRx Cost Optimization Program Update Click to Enlarge The New York State Medicaid Pharmacy Program (NYRx) has expanded its Cost Optimization Program, effective July 16, 2026, by adding additional high-cost drug formulations and dosages that are significantly more expensive than

PULSE Pulse 6/26/2026: NYRx Updates: Resources Available for Review

NYRx Updates: Resources Available for Review Click to Enlarge MSSNY recognizes that keeping pace with Medicaid pharmacy policy changes can be challenging amid growing administrative responsibilities. We encourage physicians, practice managers, billing teams, and clinical staff to review the available

PULSE 4/17/2026: Payment & Practice: Turning Complex Payer Challenges Into $38 Million Recovered Revenue

Payment & Practice: Turning Complex Payer Challenges Into $38 Million Recovered Revenue Click to Enlarge Key Point: MSSNY’s Payment and Practice team has recovered $38 million since 2021, including $10.8 million so far in 2026, directly returning revenue to physician practices.Why It

Go to Top